Home › Funds › Privium Fund Management B.V. › QURE

Privium Fund Management B.V. position in QURE

UNIQURE NV · Health Care

Privium Fund Management B.V. reported holding 216,197 shares of QURE (UNIQURE NV) in its Q3 2026 13F filing — a position valued at US$5.2M, representing 1.01% of its reported portfolio and ranking #21 among its reported holdings. Privium Fund Management B.V. has disclosed QURE holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)216.20K sh
Reported value held$5.22M
Portfolio Weight1.01%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Privium Fund Management B.V.'s QURE position evolved

Privium Fund Management B.V. first disclosed a stake in QURE in Q3 2023 at 281,606 shares (US$1.9M). The position peaked in Q3 2025 at 386,000 shares, worth US$22.5M. Across 13 filings, Privium Fund Management B.V. increased the stake 6 time(s), trimmed it 5 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 216,197 shares valued at US$5.2M — a reduction of -112,125 shares quarter over quarter.. Notable position changes include a 58% increase in Q4 2023 (shares fell 23% over the following quarter), a 33% trim in Q2 2026 (shares fell 48% over the following quarter), a 34% trim in Q3 2026 (shares fell 1% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 281.61K $1.89M New
Q4 2023 444.15K $3.08M Add
Q1 2024 578.91K $3.01M Add
Q2 2024 640.42K $2.57M Add
Q3 2024 744.92K $3.67M Add
Q4 2024 742.16K $13.11M Hold
Q1 2025 579.14K $6.14M Reduce
Q2 2025 447.49K $6.26M Reduce
Q3 2025 386.00K $22.53M Reduce
Q4 2025 416.27K $9.96M Add
Q1 2026 486.52K $7.95M Add
Q2 2026 328.32K $15.12M Reduce
Q3 2026 216.20K $5.22M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About QURE and 13F data

QURE (UNIQURE NV) is a Health Care company. 57 other funds we track also report a position in QURE — the largest reported positions include Avoro Capital Advisors LLC (US$309.9M), RTW INVESTMENTS, LP (US$181.5M), ORBIMED ADVISORS LLC (US$83.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding QURE

All QURE fund holders →

FAQ

How long has Privium Fund Management B.V. held QURE?

Privium Fund Management B.V. has disclosed QURE holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Privium Fund Management B.V.'s current position in QURE?

As of Q3 2026, Privium Fund Management B.V. holds 216.20K shares of QURE (UNIQURE NV), valued at $5.22M, representing 1.01% of its reported portfolio and ranking #21.

Has Privium Fund Management B.V. been buying or selling QURE?

In the latest 13F filing (Q3 2026), Privium Fund Management B.V. reduced its position in QURE. The position peaked in Q3 2025 at 386.00K shares.

Which other funds hold QURE?

Other major institutional holders of QURE include Avoro Capital Advisors LLC, RTW INVESTMENTS, LP, ORBIMED ADVISORS LLC, among 57 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.